The Trojan Horse of MIPS
By Sam Reynolds, VR-Zone
January 28, 2014
MIPS presents a game changing threat to the CPU side of the mobile SoC world, but nobody wants to address it.
When asked at CES about the up-and-coming MIPS-powered Warrior CPU mobile platform due out later this year, Johan Lodenius, Chief Marketing Officer of MediaTek said something bizarre: “Imagination is a big partner of ours. We use MIPS processors in some of the WiFi products we offer. We use graphics processors from from Imagination.”
Lodenius isn’t wrong; on the surface that’s a fair breakdown of the relationship between the two companies. MIPS has been used in dozens of different devices in some form for years and Imagination’s PowerVR platform is a widely used GPU core. It would be easier to list the companies that use PowerVR in their products than the ones that don’t
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- MIPS: Underdog or Dead Horse?
- Analysis: Dell has dragged the Linux-ARM Trojan horse inside the Wintel PC
- MIPS Drives Real-Time Intelligence into Physical AI Platforms
- Arteris and MIPS Partner on High-Performance RISC-V SoCs for Automotive, Datacenter and Edge AI
- MIPS Releases P8700, Industry's First High-Performance AI-Enabled RISC-V Automotive CPU for ADAS and Autonomous Vehicles
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design